Wako和光纯药Vitronectin (aa 20-398), Human, Recombinant, Liquid

Cell Adhesion Protein

Vitronectin (aa 20-398), Human, Recombinant, Liquid

Vitronectin is a 478 amino-acid glycoprotein found in serum and the extracellular matrix. Similar to other extracellular matrix proteins (such as fibronectin and laminins), it is classified as a cell adhesion protein. Vitronectin is multifunctional; in addition to promoting cell adhesion and spreading, it plays a role in both the complement and coagulation cascades.
FUJIFILM Wako’s vitronectin is a recombinant protein. It lacks the N-terminal signal peptide and thus contains amino-acid residues 20-398. This product is ideal for functional studies of vitronectin in the areas of tissue repair and regeneration. It can also be used as a chemically-defined biomaterial for various cell culture applications, including scaffold construction.

  • Application Data
  • Product List
  • Related Product List
  • Related Information

Application Data

[Cell Morphology]
Vitronectin (aa 20-398), Human, Recombinant, Liquid
[Expression of Pluripotency Markers]
Vitronectin (aa 20-398), Human, Recombinant, Liquid

Human iPS cells were passaged six times using 6-well plates coated with this product. The maintenance of the undifferentiated state in these cells was confirmed by the expression of the indicated pluripotency markers.

Cell Line: hiPS201B7
Medium: StemSure®® hPSC medium Δ (Product Code: 197-17571) containing 32 ng/mL bFGF (Product Code: 060-05383)

< Product Information >

Purity ≥90% (SDS-PAGE)
Expression system E. coli
Form Liquid
Concentration 0.5mg/mL
Formulation 20mM Tris-HCl, pH8.0 (Contains NaCl, KCl, EDTA, arginine, DTT, and glycerol)

Product List

  • Open All
  • Close All

Related Product List

  • Open All
  • Close All

Related Information

Category

  1. Cell Culture
  2. Animal Cell Culture
  3. Biomaterial
  1. Cell Culture
  2. Stem Cell Culture
  3. Extracellular Matrix / Cell Coating

Product content may differ from the actual image due to minor specification changes etc.

Share

  • Twitter
  • Facebook
  • LinkedIn